1 active not recruiting, 1 recruiting. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow ANCA Associated Vasculitis: new trials by email Literature Review of ANCA Associated Vasculitis trials Research Report on ANCA Associated Vasculitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases CAR T cell - Lupus Erythematosus, Systemic, System; Sclerosis | Phase 1 / Phase 2 | Recruiting | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 8 | 2024-11-29 | 2025-04-11 |
| CARTIMMUNE: Study of Patients With Autoimmune Diseases Receiving KYV-101 KYV-101, Cyclophosphamide, Fludarabine - Idiopathic Inflammatory Myopathies, Diffuse Cutaneous Systemic Sclerosis | Phase 1 | Active not recruiting | David Porter | 24 | 2024-08-05 | 2026-09-21 |
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (2) · Scleroderma, Diffuse (2) · Dermatomyositis (1) · Lupus Erythematosus, Systemic (1) · Lupus Nephritis (1) · Myositis (1) · Polymyositis (1)
Autoimmune Diseases (2) · Cardiovascular Diseases (2) · Connective Tissue Diseases (2) · Immune System Diseases (2) · Muscular Diseases (2) · Musculoskeletal Diseases (2) · Nervous System Diseases (2) · Neuromuscular Diseases (2) · Scleroderma, Systemic (2) · Skin Diseases (2) · Skin Diseases, Vascular (2) · Skin and Connective Tissue Diseases (2) · Systemic Vasculitis (2) · Vascular Diseases (2) · Vasculitis (2)
Cyclophosphamide (1) · Immunotherapy, Adoptive (1) · fludarabine (1)
David Porter (1) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1)
Italy (1) · United States (1)